Study of Tamoxifen in Well Differentiated Neuroendocrine Tumors and Hormone Receptor Positive Expression
Clinical trial NCT03870399 · COMPLETED
Trial details
- NCT number
- NCT03870399
- Sponsor
- AC Camargo Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-13
- Primary completion
- 2023-05-13
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.